buy reap benefit organ growth invest
strong result robust organ growth order
expect strong growth continu driven
healthi order backlog salesforc addit
reiter buy rate rais target price
organ field order grew good underli growth hvac
fire secur end market order backlog grew y-o-i
organ provid visibl sale grew organ
y-o-i slightli better hsbce bbg consensu
adj ebit margin increas y-o-i driven higher volum
product savings/cost synergi off-set somewhat salesforc addit adj
ep continu oper our/consensu estim
manag rais adj ep guidanc vs
earlier driven higher organ growth margin expans lower financ
aug
year
charg share count compar stand bbg consensu
invest thesi sale power solut batteri busi complet
compani portfolio transform pure-play build
technolog solut provid favour structur growth profil driven
increas iot adopt believ core portfolio higher
convers lower capit intens better focu margin expans improv
financi flexibl would also posit well benefit strateg
opportun hvac industri
maintain buy rate rais tp shift valuat johnson
control pe-bas valuat sotp methodolog sale power solut
batteri busi complet appli target multipl
averag forward pe build effici peer appli multipl
forward adj net incom arriv fair valu equat
revis target price vs earlier new target price
impli upsid reiter buy rate see visibl
hsbc secur capit market india privat limit
global co-head industri research
path double-digit net incom continu oper growth
compound-annual-growth-rate manag deliv oper execut synergi
employ non-u affili hsbc secur usa inc
registered/ qualifi pursuant finra regul
target improv gener
report must read disclosur analyst certif
disclosur appendix disclaim form part
issuer report hsbc secur capit
view hsbc global research
year
base hsbc ep dilut
board member
employe cost revenu
ghg intens energi intens measur kg kwh respect revenu usd
note price close aug
year
flow oper
flow invest
chang net debt
ratio growth per share analysi
year
cf operations/net debt
control increl
build field order sale organ growth y-o-i
deploy power solut sale proce johnson control use
reduc exist debt complet repurchas share
remain compani plan continu share repurchas
keep flexibl fill product line gap
except item signific special item result follow
releas indemnif reserv due favor resolut relat
post-sal tax conting previous divest tyco busi non-cash
asset impair charg relat disposit non-cor busi report held
sale charg relat environment remedi cost associ
facil marinett wisconsin discret period tax charg relat primarili
newli enact regul relat tax reform pre-tax gain
connect sale power solut
chang estim
make chang estim follow result updat guidanc
utilis proce sale power solut batteri busi
expect sale organ sale growth new
ep within guidanc
new ep driven organ sale growth margin expans
share repurchas new ep driven
organ sale growth margin expans share repurchas
johnson control chang estim
valuat risk
shift valuat johnson control pe-bas valuat sotp methodolog
sale power solut batteri busi complet appli target
multipl averag forward pe build effici peer allegion
us nr ir us nr schneider
appli multipl forward adj net incom arriv fair valu
equat revis target price vs earlier new target price
impli upsid reiter buy rate see visibl path
double-digit net incom continu oper growth forecast compound-annual-growth-rate
manag deliv oper execut synergi target improv
manag abl realis state synergi target target
cost benefit synergi product howev synergi realis depend
well compani execut integr miss state target could
downturn us non-residenti market could impact earn neg
compani exposur commerci institut market materi
deterior us non-residenti market could put downward pressur forecast
compani cut long-term target could dent manag credibl impact
